Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAPDH | P04406 | 2/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 2/20 | 1.00 |
| ▸ | DDAH1 | O94760 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | BACE1 | P56817 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.53 |
| ▸ | FPR2 | P25090 | 2/20 | 0.53 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.50 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Hydroxynon-2-Enal SCHEMBL30767210 | 1.00 | GAPDH (1.00) | GAPDHTRPA1DDAH1MAPTACHE | |
| 4-Hydroxynon-2-Enal SCHEMBL2890601 | 1.00 | GAPDH (1.00) | GAPDHTRPA1DDAH1MAPTACHE | |
| 4-Hydroxynon-2-Enal SCHEMBL3920 | 1.00 | GAPDH (1.00) | GAPDHTRPA1DDAH1MAPTACHE | |
| 4-Hydroxynon-2-Enal SCHEMBL2890600 | 1.00 | GAPDH (1.00) | GAPDHTRPA1DDAH1MAPTACHE | |
| SCHEMBL8309537 | 0.98 | GAPDH (0.96) | GAPDHTRPA1DDAH1MAPTACHE | |
| 4-Hydroxynon-2-Enal SCHEMBL2267834 | 0.98 | GAPDH (0.96) | GAPDHTRPA1DDAH1MAPTACHE | |
| SCHEMBL8309540 | 0.98 | GAPDH (0.96) | GAPDHTRPA1DDAH1MAPTACHE | |
| SCHEMBL28058254 | 0.98 | GAPDH (0.96) | GAPDHTRPA1DDAH1MAPTACHE | |
| SCHEMBL8304537 | 0.98 | GAPDH (0.96) | GAPDHTRPA1DDAH1MAPTACHE | |
| SCHEMBL8304538 | 0.98 | GAPDH (0.96) | GAPDHTRPA1DDAH1MAPTACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7250 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104986-A1 | NEW MOLECULES AND THEIR USE IN THE TREATMENT OF PATHOLOGIES RELATED TO OXIDATIVE STRESS | FIDIA FARMACEUTICI S.P.A. (IT) | 2026-05-21 | — | — | WO | claimed |
| CN-122032334-A | Composite oxygenation membrane with active aldehyde removal function, and preparation method and application thereof | 大连理工大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12582704-B2 | Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol | PICOENTECH Co., LTD. (KR) | 2026-03-24 | — | — | US | claimed |
| EP-4684214-A2 | BIOMARKERS OF AMYOTROPHIC LATERAL SCLEROSIS AND USES THEREOF | The Methodist Hospital (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-12517110-B2 | Noninvasive detection of cancer originating in tissue outside the lung using exhaled breath | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2026-01-06 | — | — | US | claimed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-12473342-B2 | Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosis | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-11-18 | — | — | US | claimed |
| WO-2002004029-A1 | OLFACTORY NEURON CULTURES AND METHOD OF MAKING AND USING THE SAME | PANACEA PHARMACEUTICALS, INC. (US) | 2002-01-17 | — | — | WO | claimed |
| US-20020002270-A1 | PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME | MOLECULAR GERIATRICS CORPORATION | 2002-01-03 | — | — | US | claimed |
| WO-2001068119-A1 | ATHEROSCLEROSIS VACCINE | FORSKARPATENT I SYD AB (SE) | 2001-09-20 | — | — | WO | claimed |
| WO-2000078807-A1 | PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME | MOLECULAR GERIATRICS CORPORATION (US) | 2000-12-28 | — | — | WO | claimed |
| EP-0968230-A1 | OXIDIZED FRAGMENTS OF APOLIPOPROTEIN B AND THEIR USE | UNIVERSITY OF LEICESTER (GB) | 2000-01-05 | — | — | EP | claimed |
| WO-1999004268-A9 | LIPID HYDROPEROXIDES TO DETECT BRAIN INJURY | GEN HOSPITAL CORP (US) | 1999-04-22 | — | — | WO | claimed |
| WO-1999004268-A1 | LIPID HYDROPEROXIDES TO DETECT BRAIN INJURY | THE GENERAL HOSPITAL CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| WO-1998042751-A1 | OXIDISED FRAGMENTS OF APOLIPOPROTEIN B AND THEIR USE | UNIVERSITY OF LEICESTER (GB) | 1998-10-01 | — | — | WO | claimed |
| EP-0833901-A1 | METHOD FOR IDENTIFYING ALZHEIMER'S DISEASE THERAPEUTICS USING TRANSGENIC ANIMAL MODELS | Athena Neurosciences, Inc. (US) | 1998-04-08 | — | — | EP | claimed |
| WO-1996040896-A1 | METHOD FOR IDENTIFYING ALZHEIMER'S DISEASE THERAPEUTICS USING TRANSGENIC ANIMAL MODELS | ATHENA NEUROSCIENCES, INC. (US) | 1996-12-19 | — | — | WO | claimed |